| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/09/2014 | EP2713776A1 Antioxidant composition for the reduction of the causes of reduced male reproductive capacity |
| 04/09/2014 | EP2713727A1 Combination of mek inhibitors and selective inhibitors of aurora a kinase |
| 04/09/2014 | CN103717737A Cancer treatment and/or prevention drug composition |
| 04/09/2014 | CN103717238A Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 04/09/2014 | CN103717219A Left ventricular diastolic function improving agent |
| 04/09/2014 | CN103717212A A topical formulation for treatment of hyperkeratotic skin |
| 04/09/2014 | CN103705926A Pharmaceutical composition used for preventing primary tumor metastasis after exairesis |
| 04/09/2014 | CN103705925A Medicine composition and method for inhibiting PI3K/AKT/mTOR signaling pathways |
| 04/09/2014 | CN103705924A Combined application of miR-1255a and tumor treating medicine |
| 04/09/2014 | CN103705923A Method and reagent used for inhibiting tumor metastasis |
| 04/09/2014 | CN103705922A Pharmaceutical composition for external use adopting glucocorticoid as active component |
| 04/09/2014 | CN103705491A Diabetes acupoint therapy sugar conversion paste |
| 04/09/2014 | CN103705463A Nose temperature-sensitive type hydrogel spray |
| 04/09/2014 | CN103705458A Oil injection containing nonsteroidal anti-inflammatory drugs/polyethylene glycol drug-loading particles |
| 04/09/2014 | CN103705455A Injection containing non-steroidal anti-inflammatory drug and prepared by use of poloxamer and oily medium |
| 04/09/2014 | CN103705452A Antibacterial drug injection containing poloxamer 407 and oily medium |
| 04/09/2014 | CN103705442A In situ lipid gel drug preparation, preparation method and use thereof |
| 04/09/2014 | CN103705439A Lipid gel medicinal preparation, preparation method thereof and purpose thereof |
| 04/09/2014 | CN103705438A Method for spinning aptamer modified polymer systems into fibrous membranes through electrostatic spinning and applying fibrous membranes to controlled release |
| 04/09/2014 | CN102703060B Targeted tracing noble metal fluorescence probe and anti-tumor prodrug |
| 04/09/2014 | CN102008628B Medicament for treating female genital tract virus infection and preparation method of sustained-release preparation of medicament |
| 04/09/2014 | CN101406454B Low molecular weight chitosan modified liposomes and preparation method thereof |
| 04/08/2014 | US8691799 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 04/08/2014 | US8691776 Synthesis of high molecular weight iron-saccharidic complexes |
| 04/08/2014 | US8691230 Methods for inhibiting hematopoiesis with a hedgehog antagonist |
| 04/08/2014 | US8691216 Methods of using regenerative cells to promote wound healing |
| 04/08/2014 | US8691209 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 04/08/2014 | US8691205 Mono- and di-PEG IL-10 production; and uses |
| 04/08/2014 | CA2685208C Methods and compositions of inhibiting complement and cellular activation with dextran sulfate |
| 04/08/2014 | CA2673483C Compositions of chk1 inhibitors |
| 04/08/2014 | CA2629046C Abuse resistant transmucosal drug delivery device |
| 04/08/2014 | CA2624568C Oligouronate treatment |
| 04/08/2014 | CA2551787C Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent |
| 04/08/2014 | CA2378402C Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/03/2014 | WO2014052780A2 Compositions and methods of use of an inappetance-controlling compound |
| 04/03/2014 | WO2014052550A1 Use of parp inhibitors to treat breast cancer |
| 04/03/2014 | WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same |
| 04/03/2014 | WO2014050779A1 Combination of gsk3 inhibitor and anti-dr5 antibody |
| 04/03/2014 | WO2014050717A1 Skin condition amelioration agent |
| 04/03/2014 | WO2014050134A1 Therapeutic agent for dyslipidemia |
| 04/03/2014 | WO2014049549A1 Combination therapy using belinostat and trabectedin |
| 04/03/2014 | WO2014049144A1 Composition for use as a medicine or dietetic food in the prevention and/or treatment of diabetes and diabetes associated diseases |
| 04/03/2014 | WO2014049071A1 Modulators of androgen synthesis |
| 04/03/2014 | WO2014048881A1 Combination of regorafenib and acetylsalicylic acid for treating cancer |
| 04/03/2014 | WO2014048584A1 Composition containing lysine as a nutritional supplement or treatment in the case of herpes |
| 04/03/2014 | WO2014048071A1 Method and pharmaceutical composition for inhibiting pi3k/akt/mtor signal path |
| 04/03/2014 | WO2014047783A1 Pharmaceutical composition containing triptolide and triptolide derivative and bcl-2 inhibitor and use thereof |
| 04/03/2014 | WO2014047782A1 Pharmaceutical composition containing resveratrol and resveratrol derivative and bcl-2 inhibitor and use thereof |
| 04/03/2014 | US20140094499 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
| 04/03/2014 | US20140094488 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors |
| 04/03/2014 | US20140094486 Solid state forms of hiv inhibitor |
| 04/03/2014 | US20140094485 Solid state forms of hiv inhibitor |
| 04/03/2014 | US20140094469 Methods and compositions for safe and effective treatment of erythema |
| 04/03/2014 | US20140094459 Tyrosine Kinase Inhibitors |
| 04/03/2014 | US20140094457 Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated rna decay |
| 04/03/2014 | US20140094452 Rapid Onset Liquid Midazolam Composition for Buccal Administration |
| 04/03/2014 | US20140094449 Treatment of bipolar disorder |
| 04/03/2014 | US20140094448 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 04/03/2014 | US20140094444 Compositions and methods for tissue engineering and cell based therapies |
| 04/03/2014 | US20140094442 Combinations comprising anti-muscarinic agents and corticosteroids |
| 04/03/2014 | US20140094437 High alcohol content foaming compositions |
| 04/03/2014 | US20140094416 Sparc angiogenic domain and methods of use |
| 04/03/2014 | US20140094408 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 04/03/2014 | US20140094406 Chimeric fibroblast growth factor 21 proteins and methods of use |
| 04/03/2014 | US20140094403 Enopeptins, uses thereof, and methods of synthesis thereto |
| 04/03/2014 | US20140094399 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/03/2014 | US20140093592 Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
| 04/03/2014 | US20140093576 Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures |
| 04/03/2014 | US20140093558 Stable crystal modifications of dotap chloride |
| 04/03/2014 | US20140093557 Exosomal compositions and methods for the treatment of disease |
| 04/03/2014 | US20140093545 Antibacterial pharmaceutical preparation |
| 04/03/2014 | US20140093539 Protein a compositions and methods of use |
| 04/03/2014 | US20140093521 Therapeutic dll4 binding proteins |
| 04/03/2014 | US20140093516 Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor |
| 04/03/2014 | US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9) |
| 04/03/2014 | US20140093511 Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 04/03/2014 | US20140093505 Pyridonaphthyridine PI3K/MTOR Dual Inhibitors and Preparation and Use Thereof |
| 04/03/2014 | US20140093503 Taxane and Abeo-Taxane Analogs |
| 04/03/2014 | US20140093502 Immunosuppressive Combination and Its Use in the Treatment or Prophylaxis of Insulin-producing Cell Graft Rejection |
| 04/03/2014 | US20140093497 Anti-cd40 antibodies and uses thereof |
| 04/03/2014 | US20140093489 Nutritional supplements for eye health and related methods |
| 04/03/2014 | US20140093454 Human Monoclonal Antibodies Against CD20 |
| 04/03/2014 | US20140091047 Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer |
| 04/03/2014 | DE102013200256B3 Detecting tumor cells in samples of human or animal tissue, comprises treating sample with complex of fluorophore as guest and macrocyclic material as host, and then irradiating with a light that is suitable for exciting the fluorophore |
| 04/02/2014 | EP2712628A1 Composition for use as a medicine or dietetic food, in particular in the prevention and/or treatment of Diabetes and diabetes associated diseases |
| 04/02/2014 | EP2712320A1 Method for egfr directed combination treatment of cancer |
| 04/02/2014 | EP2712318A1 Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmalogical treatment of gastric hyperacidity |
| 04/02/2014 | EP2712314A1 Drug-free compositions and methods for diminishing peripheral inflammation and pain |
| 04/02/2014 | CN103690956A Hemostatic powder and preparation method thereof |
| 04/02/2014 | CN103690955A Ticagrelor-containing drug composition as well as preparation method and application thereof |
| 04/02/2014 | CN103690954A Cardiovascular protection medicinal composition and use thereof |
| 04/02/2014 | CN103690953A Animal bite or scratch emergency treatment liquid as well as composition and preparation method thereof |
| 04/02/2014 | CN103690952A Compound drug for treating livestock and poultry escherichia coli infected diseases |
| 04/02/2014 | CN102827246B Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
| 04/02/2014 | CN102702454B PH response four-arm star block copolymer and preparation method and application thereof |
| 04/02/2014 | CN102670483B Electrostatic spinning fiber membrane preparation for treating hyperlipidemia and preparation method thereof |
| 04/02/2014 | CN101897969B Use of complement inhibitors in preparing medicines for preventing or treating tissure damage |
| 04/02/2014 | CN101332302B Formula for preparing anti-eczema and cutitis products and preparation method thereof |
| 04/01/2014 | US8685994 Analgesic combination of oxycodone and celecoxib |
| 04/01/2014 | US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them |